As of 2025-07-09, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 76.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 128.74 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is -40.3%.
The range of the Relative Valuation is 58.34 - 96.90 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 24.1x | 21.7x |
| Forward P/E multiples | 17.2x - 24.5x | 21.9x |
| Fair Price | 58.34 - 96.90 | 76.83 |
| Upside | -54.7% - -24.7% | -40.3% |
| Date | P/E |
| 2025-07-03 | 41.79 |
| 2025-07-02 | 41.88 |
| 2025-07-01 | 41.43 |
| 2025-06-30 | 40.68 |
| 2025-06-27 | 40.59 |
| 2025-06-26 | 41.01 |
| 2025-06-25 | 41.36 |
| 2025-06-24 | 41.48 |
| 2025-06-23 | 40.71 |
| 2025-06-20 | 40.96 |
| 2025-06-18 | 41.20 |
| 2025-06-17 | 40.42 |
| 2025-06-16 | 40.46 |
| 2025-06-13 | 40.26 |
| 2025-06-12 | 40.46 |
| 2025-06-11 | 40.19 |
| 2025-06-10 | 40.38 |
| 2025-06-09 | 40.69 |
| 2025-06-06 | 40.58 |
| 2025-06-05 | 40.33 |
| 2025-06-04 | 40.30 |
| 2025-06-03 | 40.46 |
| 2025-06-02 | 40.31 |
| 2025-05-30 | 39.81 |
| 2025-05-29 | 40.02 |
| 2025-05-28 | 39.82 |
| 2025-05-27 | 39.69 |
| 2025-05-23 | 38.90 |
| 2025-05-22 | 38.55 |
| 2025-05-21 | 39.02 |
| 2025-05-20 | 39.80 |
| 2025-05-19 | 39.75 |
| 2025-05-16 | 39.17 |
| 2025-05-15 | 38.92 |
| 2025-05-14 | 38.44 |
| 2025-05-13 | 37.82 |
| 2025-05-12 | 38.98 |
| 2025-05-09 | 37.45 |
| 2025-05-08 | 38.03 |
| 2025-05-07 | 39.36 |
| 2025-05-06 | 38.49 |
| 2025-05-05 | 35.52 |
| 2025-05-02 | 35.50 |
| 2025-05-01 | 34.50 |
| 2025-04-30 | 34.85 |
| 2025-04-29 | 34.71 |
| 2025-04-28 | 34.46 |
| 2025-04-25 | 34.54 |
| 2025-04-24 | 34.23 |
| 2025-04-23 | 33.41 |